AI Agents and Patient-Level Data – From Confirmation of Diagnosis to Insights
Join us on February 4, 2026, for an engaging discussion on how AI agents are transforming the way patient-level data is collected, validated, and turned into powerful insights. “AI Agents and Patient-Level Data – From Confirmation of Diagnosis to Insights” Presented by Wes Michael, President of Rare Patient Voice, and Inder Jaggi, CEO of Clinakos […]
Clinakos at JPM Healthcare Conference 2026
Join Clinakos Inc. at the J.P. Morgan Healthcare Conference 2026, where the future of medicine is shaped by insight, innovation, and collaboration. 👥 While many in our ecosystem are still evaluating how AI Agents can transform Life Sciences Drug development and Commercialization, our team will be at the conference to share how our clients are […]
FDA’s announcement – agentic AI solutions for reviewing new drug applications
In December 2025, the U.S. Food and Drug Administration (FDA) officially deployed Agentic AI capabilities across all agency teams — marking a major milestone in the modernization of regulatory science. These advanced systems can reason, plan, and execute multi-step workflows, supporting complex functions like review validation, post-market surveillance, compliance, and administrative automation. Agentic AI represents […]
Live at Piper Sandler
Piper Sandler this year was a powerful reminder of how quickly the ground is shifting under our feet for life sciences & healthcare companies. As CEO of Clinakos Inc., I walked away with a few clear learnings that will shape my thinking for 2025 and beyond. 👇 Here are my biggest takeaways from four days […]
Pancreatic Cancer Awareness Month
🎗️ Pancreatic cancer remains one of the deadliest cancers, accounting for about 3% of all cancers in the U.S. but nearly 8% of all cancer deaths. In 2025, an estimated 67,440 Americans will be diagnosed, and about 51,980 are expected to die from the disease. The overall 5-year relative survival rate is just 13% — […]
The power of Multi-omics
Precision medicine is revolutionizing healthcare by moving from a one-size-fits-all approach to truly personalized care. A recent article published in Nature, states how the genomics revolution underpins the P4 healthcare model: predictive, preventive, personalized, and participatory medicine. Link to the article here. 🔬 This transformation is fueled by advances in genomics and the integration of […]
We will be at the Piper Sandler 2026 Conference
Big ideas meet bold insights in New York City this December! 🗽 I’m excited to share that I’ll be attending the Piper Sandler 37th Annual Healthcare Conference, happening December 2–5, 2025 — and I look forward to connecting with the industry’s most forward-thinking healthcare leaders. 🌟 At Clinakos, we’re harnessing the power of Integrated Patient […]
RWE prominence in FDA approval
A recent Springer June 2025 publication highlights RWE’s growing role in supporting safety and efficacy evaluations in supplemental FDA approvals—especially in oncology, which represented 43.6% of submissions with RWE. 📊🧬 RWE provides complementary insights beyond traditional clinical trials—now informing every stage of the product lifecycle, with regulatory bodies increasingly using it to guide drug development, […]
Inder Jaggi’s Highlights From Our Webinar
Earlier this week, I had the privilege of presenting a webinar, “Applying Patient-Level Data & AI in Rare Diseases & Oncology,”. We closed the session by demonstrating how AI can reduce up to 40% workloads for key functions like medical affairs, commercial, market research, and clinical. I want to thank everyone who joined, and I […]
NIH Strategic Data Plan
The National Institutes of Health (NIH) unveiled its ambitious 2025-2030 Strategic Plan for Data Science, highlighting a transformative vision to enhance biomedical research through innovative data science. Key priorities include making data Findable, Accessible, Interoperable, and Reusable (FAIR) — embracing global standards to maximize the impact and utility of biomedical data. This includes promoting standards […]
